Moody Aldrich Partners’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,149
Closed -$298K 209
2024
Q1
$298K Buy
2,149
+39
+2% +$4.9K 0.05% 180
2023
Q4
$262K Sell
2,110
-278
-12% -$28.4K 0.05% 173
2023
Q3
$218K Buy
+2,388
New +$269K 0.04% 187

Other funds holding DXCM

Moody Aldrich Partners's DXCM Position: Q2 2024 in Review

Moody Aldrich Partners sold out of DexCom (DXCM) in Q2 2024, closing a stake of 2,149 shares — an estimated $298K sold.

Moody Aldrich Partners first reported a position in DXCM in Q3 2023 and held it in 3 quarters. The position peaked at $298K in Q1 2024. 999 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • Moody Aldrich Partners reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • Moody Aldrich Partners sold 2,149 DexCom shares in Q2 2024, an estimated $298K.
  • Moody Aldrich Partners first reported a position in DexCom in Q3 2023 and held it in 3 quarters.
  • Moody Aldrich Partners's DexCom position peaked at $298K in Q1 2024.
  • 999 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Moody Aldrich Partners's 13F filing for Q2 2024, filed 24 Jul 2024.